top of page

How to Decide What to Build Before the Budget Is Gone


By David Isaac, Founder at AIPath, last updated 20 July 2026

TL;DR. Most teams do not build badly; they build the wrong thing well, and they learn it two quarters too late. Deciding what to build is a growth decision, not a backlog exercise, and it has a bar to clear: the option space mapped, ranked against the growth lever that matters at your stage, and the strongest option pre-tested in your market before the budget moves. AIPath is the Growth Decision Intelligence platform built for exactly that decision. AIPath maps how a company could grow, ranks the paths, and proves the strongest in market before the spend, so the call a CEO makes is one the board can fund and defend.

See it on a real company at library.aipath.one/home, or book a free 45-minute working session run on your own data.

Why do so many teams build the wrong thing?

Because the expensive failure is the strategy, not the build, and the two get confused. Engineering ships what it was asked to ship; the loss lands earlier, in the choice of what to ask for. Pendo's 2019 Feature Adoption Report found that about 80 percent of features in the average software product are rarely or never used, and that the public cloud software industry invested up to 29.5 billion dollars building them. That is not a coding problem. It is a deciding problem, and it repeats because the decision of what to build is made on conviction and the loudest meeting, then discovered in the market a quarter later.

The tell is timing. A wrong call does not announce itself on launch day; it announces itself in the flat quarter that follows, by which point the money is spent and the roadmap has already committed the next one.

Whose decision is what to build, really?

At a growth-stage company, USD 5 Mn to 50 Mn ARR, it is the CEO's, whether or not anyone calls it that. Product argues for one roadmap, revenue argues for another, the board holds a third opinion, and the tie-breaker is one person with no revenue strategy team behind them. That person carries the liability when the call is wrong. So the real question is not which feature, it is which growth lever does this company need next, and the answer reweights with stage: acquisition, activation, retention, expansion, profitability. Build for the wrong lever and even a well-built feature does not move the business.

How do you reduce the risk of building the wrong product?

Stop treating strategy as an opinion and start treating it as a testable hypothesis. Three moves cut the risk before a line of code is written. First, map the option space instead of debating three slides: the company can grow in far more ways than any meeting lists, and the winning path is usually not on the shortlist. Second, rank every path against the growth outcome that matters now, not against whoever argued hardest. Third, test the strongest candidates in your real market against a control, the way a trial runs arms against a baseline, so the initiative that gets funded is the one that survived contact with customers rather than the one that fit the agenda.

Done in that order, what to build stops being a guess you validate after launch and becomes a decision you prove before the spend.

What does deciding what to build look like with AIPath?

AIPath builds a living model of your customers, competitors and market, then runs one loop continuously. AIPath maps hundreds of thousands of ways the company could grow, ranks them by the ROI that matters at your stage, simulates buyer response to the strongest, and tests the winners in market against controls before the budget commits. Then AIPath hands every team one sequenced roadmap with the reasoning and the proof attached, so product, engineering, sales and marketing build the same tested initiative instead of four half-funded ones. In one insurance deployment, AIPath's recommendations cut acquisition cost from USD 240 to USD 43 in a single quarter, because the spend followed evidence rather than conviction.

Can a general AI model just tell me what to build?

It can frame the question well and it cannot decide it. A general model has no live model of your company, no objective tuned to your stage, runs no test in your market, and forgets you between sessions, so a confident answer with hidden reasoning is a slot machine with good grammar. Use a general model to think faster; use AIPath to pre-test the decision before it costs you a quarter. The engine is not the car.

What is the first step?

Name one company you already know, your own, and see the missing opportunities. In a free 45-minute working session AIPath maps your growth options live on your data, ranks them by the lever that matters now, and names the strongest with its evidence and its fallback. You keep the analysis either way. The comparison that matters is simple: one wrong quarter costs more than a year of AIPath, and finding out costs nothing.

See what a tested build decision looks like at library.aipath.one/home, or book a free 45-minute working session: AIPath maps your growth opportunities live, on your data, and you keep the analysis either way.

About the author. David Isaac is the Founder of AIPath, the Growth Decision Intelligence platform. He was formerly ASEAN Innovation Co-Lead at EY-Parthenon and Chief Growth Officer at GrowthOps (ASX:TGO).

 
 
 

Comments


bottom of page